Literature DB >> 31852254

The first case of the TARDBP p.G294V mutation in a homozygous state: is a single pathogenic allele sufficient to cause ALS?

Lucia Corrado1, Viviana Pensato2, Roberta Croce1, Alice Di Pierro1, Simona Mellone1, Eleonora Dalla Bella3, Ettore Salsano4, Elvezia Maria Paraboschi5, Mara Giordano1, Massimo Saraceno6, Letizia Mazzini6, Cinzia Gellera2, Sandra D'Alfonso1.   

Abstract

Here, we described the first amyotrophic lateral sclerosis patient presenting the c.881 G > T p.G294V TARDBP mutation in homozygous status. The patient belongs to a large pedigree from Morocco. Except for one older affected brother his parents and remaining 8 sibs are referred to be healthy and do not show any neurological sign or symptom. The lack of evidence of TARDBP deletions of any sizes, together with the presence of several AOH segments, strongly suggests that the homozygosity status of p.G294V in the proband derived from parental consanguinity. A revision of the literature and our cohorts indicates that the p.G294V mutation has been detected in only 15 additional ALS patients in heterozygosity and, except for one additional Moroccan patient, all were of Italian origin. The analysis of microsatellite markers surrounding the TARDBP gene in 8 individuals carrying the p.G294V mutation showed that the haplotypic context of the Moroccan proband is shared with most patients of European origin indicating that they carry the p.G294V mutation inherited from a common ancestor. The analysis of the 15 ALS pedigrees (from literature data and present study), strongly suggests a reduced penetrance of the p.G294V mutation since for 13 of the 15 described p.G294V ALS cases the parents did not show any neurological symptoms. This result has potentially important implications in genetic counseling, since genetic testing of a reduced penetrance mutation on pre-symptomatic individuals proves very difficult to predict the outcome based on the genotype.

Entities:  

Keywords:  TARDBP; amyotrophic lateral sclerosis; mutation

Mesh:

Substances:

Year:  2019        PMID: 31852254     DOI: 10.1080/21678421.2019.1704011

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  2 in total

1.  Identification of TARDBP Gly298Ser as a founder mutation for amyotrophic lateral sclerosis in Southern China.

Authors:  Fanxi Xu; Sen Huang; Xu-Ying Li; Jianing Lin; Xiuli Feng; Shu Xie; Zhanjun Wang; Xian Li; Junge Zhu; Hong Lai; Yanming Xu; Xusheng Huang; Xiaoli Yao; Chaodong Wang
Journal:  BMC Med Genomics       Date:  2022-08-05       Impact factor: 3.622

2.  Role of genetics in amyotrophic lateral sclerosis: a large cohort study in Chinese mainland population.

Authors:  Yong-Ping Chen; Shi-Hui Yu; Qian-Qian Wei; Bei Cao; Xiao-Jing Gu; Xue-Ping Chen; Wei Song; Bi Zhao; Ying Wu; Ming-Ming Sun; Fei-Fei Liu; Yan-Bing Hou; Ru-Wei Ou; Ling-Yu Zhang; Kun-Cheng Liu; Jun-Yu Lin; Xin-Ran Xu; Chun-Yu Li; Jing Yang; Zheng Jiang; Jiao Liu; Yang-Fan Cheng; Yi Xiao; Ke Chen; Fei Feng; Ying-Ying Cai; Shi-Rong Li; Tao Hu; Xiao-Qin Yuan; Xiao-Yan Guo; Hui Liu; Qing Han; Qing-Qing Zhou; Na Shao; Jian-Peng Li; Ping-Lei Pan; Sha Ma; Hui-Fang Shang
Journal:  J Med Genet       Date:  2021-09-20       Impact factor: 5.941

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.